查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600976

吸入器和霧化器市場：按產品、適應症、分銷類型分類 - 2025-2030 年全球預測

Inhalers & Nebulizers Market by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年吸入器和霧化器市值為93億美元，預計2024年將達到114.5億美元，複合年成長率為22.55%，到2030年將達到386.3億美元。

吸入器和霧化器市場範圍包括設計用於直接向肺部輸送藥物的設備，這對於治療氣喘、慢性阻塞性肺病（COPD）和其他肺部疾病等呼吸系統疾病至關重要。這些設備的需求源於呼吸系統疾病的日益流行以及對有效藥物傳輸機制的需求。應用領域包括醫院、診所和家庭護理環境，最終用戶範圍從兒童到老年人。市場成長受到技術進步、人們對呼吸系統疾病認知的提高以及城市污染導致的與生活方式相關的呼吸系統疾病發病率上升等因素的影響。成長機會包括整合數位健康追蹤的智慧吸入器技術創新以及擴大我們在醫療基礎設施不斷改善的新興市場的業務。

主要市場統計
基準年[2023] 93億美元
預測年份 [2024] 114.5億美元
預測年份 [2030] 386.3億美元
複合年成長率（%） 22.55%

然而，嚴格的法規環境、先進設備的高成本以及低度開發地區的意識低等挑戰可能會阻礙成長。設備不一致和程序變化也會產生限制，這些可能會影響治療效果。為了克服這些障礙，公司可以專注於開發輕型、攜帶式霧化器和具有更高準確性和患者友好介面的經濟高效吸入器等領域的創新。新的研究途徑包括由智慧吸入器促進的個人化醫療方法，可監測患者的依從性並提供回饋。市場參與者可以利用這些見解來增強產品差異化並獲得競爭優勢。策略建議包括投資研發以創建適合不同患者需求的適應性技術，並與醫療保健提供者建立夥伴關係以提供全面的服務。市場充滿活力且競爭激烈，對傳統和新解決方案的需求同步成長，重點是針對各種呼吸系統疾病的方便用戶使用型和高效設計。因此，根據消費者偏好量身定做的技術進步和產品開拓是充分發揮吸入器和霧化器市場潛力的關鍵。

市場動態：快速發展的吸入器和霧化器市場的關鍵市場洞察

供需的動態交互作用正在改變吸入器和霧化器市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球呼吸系統疾病盛行率不斷上升
    • 霧化器和數位化改進產品的採用率增加
    • 智慧吸入器製造商與軟體公司之間的數位健康夥伴關係
  • 市場限制因素
    • 智慧吸入器開發的可用性有限且成本高昂
  • 市場機會
    • 智慧吸入器設備和系統的技術進步
    • 市場主體加大投資與研發力道
  • 市場挑戰
    • 與吸入器和霧化器相關的實際問題

波特五力：駕馭吸入器和霧化器市場的策略工具

波特的五力框架是了解吸入器和霧化器市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解吸入器和霧化器市場的外部影響

外部宏觀環境因素在塑造吸入器和霧化器市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解吸入器/霧化器市場的競爭狀況

對吸入器和霧化器市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣吸入器和霧化器市場供應商的績效評估

FPNV定位矩陣是評估吸入器和霧化器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球呼吸系統疾病發生率上升
      • 霧化器數位化產品的採用增加
      • 智慧吸入器製造商與軟體公司之間的數位健康夥伴關係
    • 抑制因素
      • 智慧吸入器開發的可用性有限且高成本
    • 機會
      • 智慧吸入器設備和系統的技術進步
      • 市場參與企業增加投資和研發
    • 任務
      • 與吸入器和霧化器相關的實際問題
  • 市場區隔分析
    • 產品：廣泛使用吸入器以克服呼吸系統疾病的負擔
    • 適應症：消費者對氣喘治療中吸入器和霧化器的偏好不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化
    • 專利分析及趨勢

第6章吸入器/霧化器市場：依產品

  • 吸入器
    • 乾粉吸入器
    • 定量吸入器
  • 噴霧器
    • 噴射霧化器
    • 網狀霧化器
    • 超音波霧化器

第7章依適應症分類的吸入器/霧化器市場

  • 氣喘
  • 慢性阻塞性肺病

第 8 章依輸送模式分類的吸入器和霧化器市場

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章美洲吸入器和霧化器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太吸入器和霧化器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲吸入器/霧化器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 1nhaler 融資 250 萬美元開發永續吸入器
    • 羽扇豆科在德國為氣喘患者推出吸入器
    • 協同效應 Life Sciences推出可攜式霧化器“Nebi”

公司名單

  • AMIKO Digital Health
  • United Therapeutics Corporation
  • PARI GmbH
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC
  • H&T Presspart
  • CHIESI Farmaceutici SpA
  • Omron Corporation
  • AptarGroup, Inc.
  • 3M Company
  • ICONOVO AB
  • Beximco Pharmaceuticals Ltd.
  • Koninklijke Philips NV
  • GF Health Products, Inc.
  • Narang Medical Limited
  • Mundipharma GmbH
  • Dr Trust by Nureca Ltd.
  • Sunovion Pharmaceuticals Inc.
  • Novartis AG
  • Cipla Limited
  • Merck Group
  • Vectura Group Ltd.
  • Beurer GmbH
  • Drive DeVilbiss International
  • Sensirion AG
Product Code: MRR-434CCDA05167

The Inhalers & Nebulizers Market was valued at USD 9.30 billion in 2023, expected to reach USD 11.45 billion in 2024, and is projected to grow at a CAGR of 22.55%, to USD 38.63 billion by 2030.

The scope of the Inhalers & Nebulizers market encompasses devices designed to deliver medication directly to the lungs, crucial for managing respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. The necessity of these devices arises from the increased prevalence of respiratory ailments and the demand for efficient drug delivery mechanisms. Application areas include hospitals, clinics, and home care settings, with end-users ranging from pediatric to geriatric patients. Market growth is influenced by factors like technological advancements, increased awareness about respiratory disorders, and the rising incidence of lifestyle-related respiratory issues due to urban pollution. Opportunities for growth include innovations in smart inhaler technology that integrates digital health tracking, and expanded market presence in developing regions with escalating healthcare infrastructure improvements.

KEY MARKET STATISTICS
Base Year [2023] USD 9.30 billion
Estimated Year [2024] USD 11.45 billion
Forecast Year [2030] USD 38.63 billion
CAGR (%) 22.55%

However, challenges such as stringent regulatory environments, high costs associated with advanced devices, and limited awareness in less developed regions can impede growth. Limitations also arise from device inconsistency and technique variability that may affect treatment efficacy. To overcome these obstacles, companies can focus on innovation in areas like lightweight, portable nebulizers, and the development of cost-effective inhalers with enhanced precision and patient-friendly interfaces. Emerging research avenues include personalized medicine approaches facilitated by smart inhalers that monitor patient adherence and provide feedback. Market players can leverage these insights to enhance product differentiation and gain a competitive edge. Strategic recommendations include investing in R&D to create adaptive technology tailored to diverse patient needs and establishing partnerships with healthcare providers for comprehensive service offerings. The market is dynamic and competitive, driven by simultaneous demand for traditional and novel solutions, with an emphasis on user-friendly, efficient designs catering to a broad spectrum of respiratory conditions. Hence, aligning product development with technological advancements and consumer preferences will be key to capturing the full potential of the inhalers and nebulizers market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhalers & Nebulizers Market

The Inhalers & Nebulizers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Respiratory Diseases Globally
    • Increasing Adoption of Nebulizers and Digitally-Improved Products
    • Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
  • Market Restraints
    • Limited Availability and High Costs Associated with the Development of Smart Inhalers
  • Market Opportunities
    • Technological Advancements in Smart Inhaler Devices and Systems
    • Growing Investment and R&D by Market Players
  • Market Challenges
    • Practical Problems Associated with Inhalers & Nebulizers

Porter's Five Forces: A Strategic Tool for Navigating the Inhalers & Nebulizers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhalers & Nebulizers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhalers & Nebulizers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhalers & Nebulizers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhalers & Nebulizers Market

A detailed market share analysis in the Inhalers & Nebulizers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhalers & Nebulizers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhalers & Nebulizers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include AMIKO Digital Health, United Therapeutics Corporation, PARI GmbH, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, H&T Presspart, CHIESI Farmaceutici S.p.A., Omron Corporation, AptarGroup, Inc., 3M Company, ICONOVO AB, Beximco Pharmaceuticals Ltd., Koninklijke Philips N.V., GF Health Products, Inc., Narang Medical Limited, Mundipharma GmbH, Dr Trust by Nureca Ltd., Sunovion Pharmaceuticals Inc., Novartis AG, Cipla Limited, Merck Group, Vectura Group Ltd., Beurer GmbH, Drive DeVilbiss International, and Sensirion AG.

Market Segmentation & Coverage

This research report categorizes the Inhalers & Nebulizers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Inhalers and Nebulizers. The Inhalers is further studied across Dry Powder Inhalers and Metered Dose Inhalers. The Nebulizers is further studied across Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer.
  • Based on Indication, market is studied across Asthma and COPD.
  • Based on Distribution Mode, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Diseases Globally
      • 5.1.1.2. Increasing Adoption of Nebulizers and Digitally-Improved Products
      • 5.1.1.3. Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Availability and High Costs Associated with the Development of Smart Inhalers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Smart Inhaler Devices and Systems
      • 5.1.3.2. Growing Investment and R&D by Market Players
    • 5.1.4. Challenges
      • 5.1.4.1. Practical Problems Associated with Inhalers & Nebulizers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Wide availability of inhalers to overcome the respiratory disease burden
    • 5.2.2. Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Patent Analysis & Trend

6. Inhalers & Nebulizers Market, by Product

  • 6.1. Introduction
  • 6.2. Inhalers
    • 6.2.1. Dry Powder Inhalers
    • 6.2.2. Metered Dose Inhalers
  • 6.3. Nebulizers
    • 6.3.1. Jet Nebulizer
    • 6.3.2. Mesh Nebulizer
    • 6.3.3. Ultrasonic Nebulizer

7. Inhalers & Nebulizers Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD

8. Inhalers & Nebulizers Market, by Distribution Mode

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Inhalers & Nebulizers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Inhalers & Nebulizers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Inhalers & Nebulizers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler
    • 12.3.2. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
    • 12.3.3. Synergy Life Science Releases Nebi, a Portable Nebulizer

Companies Mentioned

  • 1. AMIKO Digital Health
  • 2. United Therapeutics Corporation
  • 3. PARI GmbH
  • 4. Teva Pharmaceutical Industries Ltd.
  • 5. GlaxoSmithKline PLC
  • 6. H&T Presspart
  • 7. CHIESI Farmaceutici S.p.A.
  • 8. Omron Corporation
  • 9. AptarGroup, Inc.
  • 10. 3M Company
  • 11. ICONOVO AB
  • 12. Beximco Pharmaceuticals Ltd.
  • 13. Koninklijke Philips N.V.
  • 14. GF Health Products, Inc.
  • 15. Narang Medical Limited
  • 16. Mundipharma GmbH
  • 17. Dr Trust by Nureca Ltd.
  • 18. Sunovion Pharmaceuticals Inc.
  • 19. Novartis AG
  • 20. Cipla Limited
  • 21. Merck Group
  • 22. Vectura Group Ltd.
  • 23. Beurer GmbH
  • 24. Drive DeVilbiss International
  • 25. Sensirion AG

LIST OF FIGURES

  • FIGURE 1. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALERS & NEBULIZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INHALERS & NEBULIZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2030 (USD MILLION)
  • TABLE 233. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023